Asia News Network·1 min read·easy

India approves first dengue vaccine for people aged 4-60 years

India approves first dengue vaccine for people aged 4-60 years
AI Summary

India has officially approved the QDENGA dengue vaccine, developed by Takeda Biopharmaceuticals, for individuals aged 4 to 60 years. This marks the first time a dengue vaccine has received market authorization in the country.

July 21, 2026 NEW DELHI – In a major breakthrough, India has approved its first dengue vaccine, with the Drug Controller General of India (DCGI) granting market authorisation to QDENGA from Takeda Biopharmaceuticals India. The vaccine was approved fo... [1656 chars]

Continue reading on Headlinne

Create a free account to read the full article.

Read full article →
healthscience

Get the full story

Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.

Create free account

Already have an account? Sign in

India approves first dengue vaccine for people aged 4-60 years — Headlinne — headlinne